Method for analyzing rna

Patent metadata

Field	Value
Publication number	US-2021180106-A1
Application number	US-201616077366-A
Country	US
Kind code	A1
Filing date	Feb 12, 2016
Priority date	Feb 12, 2016
Publication date	Jun 17, 2021
Grant date	—

Abstract

The present invention relates to the field of RNA analysis. In particular, the invention concerns the use of one or more nucleic acid molecules for the analysis of an RNA molecule. In particular, the method is suitable for use in quality control during or following production of RNA. Furthermore, the present invention provides methods for analyzing a mixture of RNA molecules or an RNA population.

First claim

1 . A method for analyzing a sample comprising in vitro transcribed RNA, comprising determining the presence, integrity and/or quantity of at least one RNA species having a sequence comprising a target sequence in said sample using a nuclease protection assay or a molecular beacon assay.

2 . The method according to claim 1 , wherein said analysis is independent of the target sequence of the at least one RNA species.

3 . (canceled)

4 . The method according to claim 1 , wherein the nuclease protection assay comprises the following steps:
a) contacting said sample with at least one single-stranded nucleic acid molecule comprising a nucleic acid sequence which is complementary to at least a part of the sequence of the at least one RNA species in said sample and a detectable label attached to said single-stranded nucleic acid molecule under conditions sufficient to form a double-stranded nucleic acid molecule between the at least one RNA species and the single-stranded nucleic acid molecule, thereby providing a sample comprising the double-stranded nucleic acid molecule; b) contacting the sample comprising the double-stranded nucleic acid molecule with a nuclease specific for single-stranded nucleic acid molecules under conditions sufficient to degrade single-stranded nucleic acid molecules present in the sample; and c) detecting the double-stranded nucleic acid molecule by means of the detectable label.

5 . (canceled)

6 . The method according to claim 4 , wherein the at least one single-stranded nucleic acid molecule further comprises a moiety enabling immobilization of the double-stranded nucleic acid molecule.

7 . (canceled)

8 . The method according to claim 4 , further comprising after step b) and before step c) a step b1) of immobilizing the double-stranded nucleic acid molecule to a solid surface.

9 . (canceled)

10 . The method according to claim 4 , wherein the RNA species further comprises a sequence located 5′ and/or 3′ of the target sequence and wherein the at least one single-stranded nucleic acid molecule comprises a nucleic acid sequence which is complementary to said sequence located 5′ and/or 3′ of the target sequence of the at least one RNA species.

11 - 13 . (canceled)

14 . The method according to claim 4 , wherein for determining the quantity of the at least one RNA species the method additionally comprises a step c1) of generating a standard curve for the at least one single-stranded nucleic acid molecule and matching a signal obtained by detecting the double-stranded nucleic acid molecule with said standard curve.

15 . The method according to claim 4 , wherein for determining the integrity of the at least one RNA species step a) comprises contacting said sample comprising in vitro transcribed RNA with at least two single-stranded nucleic acid molecules, each comprising a nucleic acid sequence which is complementary to a different part of the sequence of the at least one RNA species and a detectable label attached to each of said single-stranded nucleic acid molecules, under conditions sufficient to form a double-stranded nucleic acid molecule between the at least one RNA species and the at least two single-stranded nucleic acid molecules.

16 - 18 . (canceled)

19 . The method according to claim 1 , wherein the molecular beacon assay comprises the following steps:
a) contacting said sample comprising in vitro transcribed RNA with at least one molecular beacon having a single-stranded portion comprising a nucleic acid sequence which is complementary to at least a part of the sequence of the at least one RNA species under conditions sufficient to form a double-stranded nucleic acid molecule between the at least one RNA species and the single-stranded portion of the at least one molecular beacon; b) detecting the double-stranded nucleic acid molecule by means of fluorescence emitted by the at least one molecular beacon.

20 - 28 . (canceled)

29 . A method for analyzing a sample comprising in vitro transcribed RNA, comprising determining the presence, integrity and/or quantity of at least one RNA species having a sequence comprising a target sequence in said sample using reverse transcription followed by quantitative PCR (RT-qPCR), wherein said analysis is independent of the target sequence of the at least one RNA species.

30 . (canceled)

31 . The method according to claim 29 , comprising the following steps:
a) contacting said sample comprising in vitro transcribed RNA with at least one primer for reverse transcription under conditions sufficient for reverse transcription, thereby providing a sample containing cDNA corresponding to the at least one RNA species; b) contacting the sample containing cDNA with at least one set of PCR primers under conditions sufficient for PCR amplification of the cDNA, wherein each PCR primer binds specifically to a part of the cDNA; and c) detecting the amplified DNA.

32 - 41 . (canceled)

42 . A method of analyzing a sample comprising different RNA species, each having a sequence comprising a target sequence and being prepared by RNA in vitro transcription, the method comprising determining the presence, integrity and/or quantity of each of the RNA species present in said sample using a nuclease protection assay, RT-qPCR or a molecular beacon assay.

43 - 45 . (canceled)

46 . The method according to claim 42 , wherein the nuclease protection assay comprises the following steps:
a) contacting said sample comprising different RNA species with single-stranded nucleic acid molecules having different nucleic acid sequences, wherein each single-stranded nucleic acid molecule comprises:
a nucleic acid sequence which is complementary to at least a part of the sequence of one RNA species within the sample, but not to sequences of other RNA species within the sample; and
a detectable label attached to said single-stranded nucleic acid molecule;
under conditions sufficient to form a double-stranded nucleic acid molecule between the one RNA species within the sample and the corresponding single-stranded nucleic acid molecule; b) contacting the sample comprising the double-stranded nucleic acid molecule with a nuclease specific for single-stranded nucleic acid molecules under conditions sufficient to degrade single-stranded nucleic acid molecules present in the sample; and c) detecting the double-stranded nucleic acid molecule by means of the detectable label.

47 - 52 . (canceled)

53 . The method according to claim 46 , wherein at least one RNA species further comprises a sequence located 5′ and/or 3′ of the target sequence and wherein at least one single-stranded nucleic acid molecule comprises a nucleic acid sequence which is complementary to said sequence located 5′ or 3′ of the target sequence of said RNA species.

54 - 56 . (canceled)

57 . The method according to claim 46 , wherein for determining the quantity of each of the RNA species the method additionally comprises a step c1) of generating a standard curve for each of the different single-stranded nucleic acid molecules and matching a signal obtained by detecting a double-stranded nucleic acid molecule with the standard curve for the corresponding single-stranded nucleic acid molecule.

58 . The method according to claim 46 , wherein for determining the integrity of each of the RNA species step a) comprises contacting said sample with d

Assignees

• Curevac Ag

Inventors

• Wochner Aniela
• Roos Tilmann
• Eber Fabian Johannes
• Hofmann Philipp

Classifications

• C12Q1/6851

  Quantitative amplification · CPC title

• C12Q2531/113

  PCR · CPC title

• C12Q2565/518

  characterised by the immobilisation of the nucleic acid sample or target · CPC title

• C12Q1/6806 Primary

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

• C12Q1/6813 Primary

  Hybridisation assays · CPC title